Enzyme-based Cholesterol-lowering Probiotic Complex

Acces sibility Controls

Implementing Organization

Project Overview

Probiotic isolate APS strain of Brevibacterium for cholesterol reduction; exclusive license from CSIR-NCL; Eureka award winner; pre-clinical trials complete

Related Research

View All

Quick Information

Area of Research

Pharmaceutical Sciences

Focus Area

Probiotics, cholesterol management

Sanction Amount

₹ Not specified

Status

Commercialised

Output

No. of Research Paper

Technologies (If Any)

No. of PhD Produced

N/A

Startup (If Any)

No. of Patents

Filed :01

Grant :00